General Infectious Disease News Articles

Infectious Dis.

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Berends E et al. – The market for N–glycosylated therapeutic proteins represents multi–billion dollars in sales and is growing more than 10% each year. This requires cost–effective production platforms that display correct and homogeneous N–glycosylation. Based on recent results, the authors propose to use mushroom–forming basidiomycetes for the production of N–glycosylated therapeutic proteins.


Related Articles

Can filamentous fungi form biofilms
Trends in Microbiology, 11/04/09    Relevance Score: 87%

In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis
Clinical and Experimental Dermatology, 11/02/09    Relevance Score: 87%

Mobile air-decontamination unit and filamentous fungal load in the hematology ward: How efficient at the low-activity mode
American Journal of Infection Control, 10/09/09    Relevance Score: 82%

Antifungal activity of the clove essential oil from Syzygium aromaticum on Candida, Aspergillus and dermatophyte species
Journal of Medical Microbiology, 10/21/09    Relevance Score: 80%

Do 3 meals a day keep fungi away
EurekAlert, 10/16/09    Relevance Score: 80%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address